CRISPR Therapeutics (NASDAQ:CRSP) Sees Large Volume Increase After Analyst Upgrade
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) saw unusually-strong trading volume on Friday after Morgan Stanley raised their price target on the stock from $30.00 to $32.00. Morgan Stanley currently has an underweight rating on the stock. Approximately 3,378,007 shares traded hands during mid-day trading, an increase of 66% from the previous […]
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) saw unusually-strong trading volume on Friday after Morgan Stanley raised their price target on the stock from $30.00 to $32.00. Morgan Stanley currently has an underweight rating on the stock. Approximately 3,378,007 shares traded hands during mid-day trading, an increase of 66% from the previous […]
